Apparent diffusion coefficient value as a biomarker reflecting morphological and biological features of prostate cancer

International Urology and Nephrology

Volumn 46, Issue 3, 2014, Pages 555-561

  Bae, Hyeyeol ^a   Yoshida, Soichiro ^a   Matsuoka, Yoh ^a   Nakajima, Hiroshi ^a   Ito, Eisaku ^a   Tanaka, Hiroshi ^b   Oya, Miyako ^a   Nakayama, Takayuki ^a   Takeshita, Hideki ^a   Kijima, Toshiki ^a   Ishioka, Junichiro ^a   Numao, Noboru ^a   Koga, Fumitaka ^a   Saito, Kazutaka ^a   Akashi, Takumi ^a   Fujii, Yasuhisa ^a   Kihara, Kazunori ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b Ochanomizu Surugadai Clinic   (Japan)

Author keywords

Biological markers; Diffusion magnetic resonance imaging; Ki 67 Antigen; Prostatic neoplasms

Indexed keywords

BIOLOGICAL MARKER; KI 67 ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER PATIENT; CANCER SIZE; CLINICAL ARTICLE; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; GLEASON SCORE; HUMAN; HUMAN TISSUE; LABELING INDEX; MALE; MIDDLE AGED; MORPHOLOGY; NUCLEAR MAGNETIC RESONANCE SCANNER; PATHOPHYSIOLOGY; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; SENSITIVITY AND SPECIFICITY; CHEMISTRY; PATHOLOGY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDY;

AGED; DIFFUSION MAGNETIC RESONANCE IMAGING; HUMANS; KI-67 ANTIGEN; MALE; MIDDLE AGED; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 84897113670     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-013-0557-1     Document Type: Article

References (24)

1. Ahmed HU, Hindley RG, Dickinson L, Freeman A, Kirkham AP, Sahu M, Scott R, Allen C, Van der Meulen J, Emberton M (2012) Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development study. Lancet Oncol 13(6):622-632. doi:10.1016/S1470-2045(12)70121-3
2. Smith DW, Stoimenova D, Eid K, Barqawi A (2012) The role of targeted focal therapy in the management of low-risk prostate cancer: update on current challenges. Prostate Cancer 2012:587139. doi:10.1155/2012/587139
3. Matsuoka Y, Numao N, Saito K, Tanaka H, Kumagai J, Yoshida S, Koga F, Masuda H, Kawakami S, Fujii Y, Kihara K (2012) Combination of diffusion-weighted magnetic resonance imaging and extended prostate biopsy predicts lobes without significant cancer: application in patient selection for hemiablative focal therapy. Eur Urol. doi:10.1016/j.eururo.2012.10.010
4. Numao N, Yoshida S, Komai Y, Ishii C, Kagawa M, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Koga F, Saito K, Masuda H, Fujii Y, Kawakami S, Kihara K (2013) Usefulness of prebiopsy multiparametric magnetic resonance imaging and clinical variables to reduce initial prostate biopsy in men with suspected clinically localized prostate cancer. J Urol. doi:10.1016/j.juro.2013.02.3197
5. Tan CH, Wang J, Kundra V (2011) Diffusion weighted imaging in prostate cancer. Eur Radiol 21(3):593-603. doi:10.1007/s00330-010-1960-y
6. Koh DM, Collins DJ (2007) Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol 188(6):1622-1635. doi:10.2214/AJR.06.1403
7. Wu LM, Xu JR, Ye YQ, Lu Q, Hu JN (2012) The clinical value of diffusion-weighted imaging in combination with T2-weighted imaging in diagnosing prostate carcinoma: a systematic review and meta-analysis. AJR Am J Roentgenol 199(1):103-110. doi:10.2214/AJR.11.7634
8. Hambrock T, Somford DM, Huisman HJ, van Oort IM, Witjes JA, Hulsbergen-van de Kaa CA, Scheenen T, Barentsz JO (2011) Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer. Radiology 259(2):453-461. doi:10.1148/radiol. 11091409
9. Kitajima K, Takahashi S, Ueno Y, Miyake H, Fujisawa M, Kawakami F, Sugimura K (2013) Do apparent diffusion coefficient (ADC) values obtained using high b-values with a 3-T MRI correlate better than a transrectal ultrasound (TRUS)-guided biopsy with true Gleason scores obtained from radical prostatectomy specimens for patients with prostate cancer? Eur J Radiol 82(8):1219-1226. doi:10.1016/j.ejrad.2013.02.021
10. Padhani AR, Liu G, Koh DM, Chenevert TL, Thoeny HC, Takahara T, Dzik-Jurasz A, Ross BD, Van Cauteren M, Collins D, Hammoud DA, Rustin GJ, Taouli B, Choyke PL (2009) Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia 11(2):102-125
11. Oto A, Yang C, Kayhan A, Tretiakova M, Antic T, Schmid-Tannwald C, Eggener S, Karczmar GS, Stadler WM (2011) Diffusion-weighted and dynamic contrast-enhanced MRI of prostate cancer: correlation of quantitative MR parameters with Gleason score and tumor angiogenesis. AJR Am J Roentgenol 197(6):1382-1390. doi:10.2214/AJR.11.6861
12. Woodfield CA, Tung GA, Grand DJ, Pezzullo JA, Machan JT, Renzulli JF 2nd (2010) Diffusion-weighted MRI of peripheral zone prostate cancer: comparison of tumor apparent diffusion coefficient with Gleason score and percentage of tumor on core biopsy. AJR Am J Roentgenol 194(4):W316-W322. doi:10.2214/AJR.09.2651
13. Kobayashi S, Koga F, Kajino K, Yoshita S, Ishii C, Tanaka H, Saito K, Masuda H, Fujii Y, Yamada T, Kihara K (2013) Apparent diffusion coefficient value reflects invasive and proliferative potential of bladder cancer. J Magn Reson Imaging. doi:10.1002/jmri.24148
14. Yoshida S, Kobayashi S, Koga F, Ishioka J, Ishii C, Tanaka H, Nakanishi Y, Matsuoka Y, Numao N, Saito K, Masuda H, Fujii Y, Kihara K (2013) Apparent diffusion coefficient as a prognostic biomarker of upper urinary tract cancer: a preliminary report. Eur Radiol. doi:10.1007/s00330-013-2805-2
15. Zelhof B, Pickles M, Liney G, Gibbs P, Rodrigues G, Kraus S, Turnbull L (2009) Correlation of diffusion-weighted magnetic resonance data with cellularity in prostate cancer. BJU Int 103(7):883-888. doi:10.1111/j.1464-410X. 2008.08130.x
16. Kasivisvanathan V, Dufour R, Moore CM, Ahmed HU, Abd-Alazeez M, Charman SC, Freeman A, Allen C, Kirkham A, van der Meulen J, Emberton M (2013) Transperineal magnetic resonance image targeted prostate biopsy versus transperineal template prostate biopsy in the detection of clinically significant prostate cancer. J Urol 189(3):860-866. doi:10.1016/j.juro.2012.10. 009
17. Moore CM, Robertson NL, Arsanious N, Middleton T, Villers A, Klotz L, Taneja SS, Emberton M (2013) Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review. Eur Urol 63(1):125-140. doi:10.1016/j.eururo.2012.06.004
18. Higano S, Yun X, Kumabe T, Watanabe M, Mugikura S, Umetsu A, Sato A, Yamada T, Takahashi S (2006) Malignant astrocytic tumors: clinical importance of apparent diffusion coefficient in prediction of grade and prognosis. Radiology 241(3):839-846. doi:10.1148/radiol.2413051276 (Pubitemid 46190551)
19. Kang Y, Choi SH, Kim YJ, Kim KG, Sohn CH, Kim JH, Yun TJ, Chang KH (2011) Gliomas: histogram analysis of apparent diffusion coefficient maps with standard- or high-b-value diffusion-weighted MR imaging-correlation with tumor grade. Radiology 261(3):882-890. doi:10.1148/radiol.11110686
20. Wieduwilt MJ, Valles F, Issa S, Behler CM, Hwang J, McDermott M, Treseler P, O'Brien J, Shuman MA, Cha S, Damon LE, Rubenstein JL (2012) Immunochemotherapy with intensive consolidation for primary CNS lymphoma: a pilot study and prognostic assessment by diffusion-weighted MRI. Clin Cancer Res 18(4):1146-1155. doi:10.1158/1078-0432.ccr-11-0625
21. Kobayashi S, Koga F, Yoshida S, Masuda H, Ishii C, Tanaka H, Komai Y, Yokoyama M, Saito K, Fujii Y, Kawakami S, Kihara K (2011) Diagnostic performance of diffusion-weighted magnetic resonance imaging in bladder cancer: potential utility of apparent diffusion coefficient values as a biomarker to predict clinical aggressiveness. Eur Radiol 21(10):2178-2186. doi:10.1007/s00330-011- 2174-7
22. Yamamoto S, Yonese J, Kawakami S, Ohkubo Y, Tatokoro M, Komai Y, Takeshita H, Ishikawa Y, Fukui I (2007) Preoperative serum testosterone level as an independent predictor of treatment failure following radical prostatectomy. Eur Urol 52(3):696-701. doi:10.1016/j.eururo.2007.03.052 (Pubitemid 47126163)
23. Yoshida S, Koga F, Kobayashi S, Ishii C, Tanaka H, Komai Y, Saito K, Masuda H, Fujii Y, Kawakami S, Kihara K (2012) Role of diffusion-weighted magnetic resonance imaging in predicting sensitivity to chemoradiotherapy in muscle-invasive bladder cancer. Int J Radiat Oncol Biol Phys 83(1):e21-e27. doi:10.1016/j.ijrobp.2011.11.065
24. Yoshida S, Masuda H, Ishii C, Tanaka H, Fujii Y, Kawakami S, Kihara K (2011) Usefulness of diffusion-weighted MRI in diagnosis of upper urinary tract cancer. AJR Am J Roentgenol 196(1):110-116. doi:10.2214/AJR.10.4632